Bone Marrow Toxicity Caused by Azathioprine in Inflammatory Bowel Disease: 27 Years of Experience.

Gut - United Kingdom
doi 10.1136/gut.34.8.1081
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

The Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine or Azathioprine

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2001English

Azathioprine-Induced Severe Bone Marrow Suppression

Case Reports in Clinical Practice
2019English

Management of Inflammatory Bowel Disease: 30 Years of Observation

Cleveland Clinic Journal of Medicine
Medicine
1990English

P293 Bone Density and Bone Metabolism in Patients With Inflammatory Bowel Disease

Journal of Crohn's and Colitis
MedicineGastroenterology
2013English

Therapeutic Effects of Mouse Bone Marrow-Derived Clonal Mesenchymal Stem Cells in a Mouse Model of Inflammatory Bowel Disease

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2015English

Bone Morphogenetic Proteins and Signaling Pathway in Inflammatory Bowel Disease

2012English

Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients With Inflammatory Bowel Disease

Canadian Journal of Gastroenterology
1999English

Review Article: Managing the Adverse Events Caused by Anti-TNF Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Utilisation of Erythrocyte 6-Thioguanine Metabolite Levels to Optimise Azathioprine Therapy in Patients With Inflammatory Bowel Disease

Gut
Gastroenterology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy